Selpercatinib is a pharmaceutical raw material that functions as a selective RET kinase inhibitor. It is used in the manufacturing of targeted cancer therapies for patients whose tumors harbor specific RET gene alterations.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Selpercatinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(RS)-mianserin hydrochloride
pharmaceutical raw material
Magnesium aspartate dihydrate
pharmaceutical raw material
Sodium dichloroacetate
pharmaceutical raw material
L-822179
pharmaceutical raw material
The international HS code for Selpercatinib (CAS 2152628-33-4) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrile
XIIOFHFUYBLOLW-UHFFFAOYSA-N
CC(C)(COC1=CN2C(=C(C=N2)C#N)C(=C1)C3=CN=C(C=C3)N4CC5CC(C4)N5CC6=CN=C(C=C6)OC)O
Sourcing Selpercatinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.